• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to: Letter to the Editor with Regard to the Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands.

作者信息

Serné Erik H, Roze Stéphane, Buompensiere Maria I, Valentine William J, de Portu Simona, de Valk Harold W

机构信息

Amsterdam UMC, Amsterdam, The Netherlands.

Vyoo Agency, Lyon, France.

出版信息

Adv Ther. 2023 May;40(5):2545-2548. doi: 10.1007/s12325-023-02431-2. Epub 2023 Mar 9.

DOI:10.1007/s12325-023-02431-2
PMID:36892809
Abstract
摘要

相似文献

1
Response to: Letter to the Editor with Regard to the Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands.对《致编辑的信》的回应：关于荷兰1型糖尿病中混合闭环系统与多次每日注射加间歇性扫描式连续血糖监测的成本效益
Adv Ther. 2023 May;40(5):2545-2548. doi: 10.1007/s12325-023-02431-2. Epub 2023 Mar 9.
2
Letter to the Editor Regarding Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently-Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands.致编辑的信：关于荷兰1型糖尿病患者中混合闭环系统与多次每日注射加间歇性扫描式连续血糖监测的成本效益比较
Adv Ther. 2023 May;40(5):2542-2544. doi: 10.1007/s12325-023-02427-y. Epub 2023 Mar 9.
3
Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands.荷兰 1 型糖尿病患者使用混合闭环胰岛素泵与多次皮下注射加间歇性扫描葡萄糖监测的成本效果比较。
Adv Ther. 2022 Apr;39(4):1844-1856. doi: 10.1007/s12325-022-02058-9. Epub 2022 Feb 28.
4
Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece.希腊1型糖尿病患者使用先进混合闭环胰岛素输送系统的成本效益分析。
Diabetes Technol Ther. 2022 May;24(5):316-323. doi: 10.1089/dia.2021.0443.
5
Successful transitioning children and adolescents with type 1 diabetes from multiple daily injections to advanced hybrid closed-loop system in 10 days: a prospective intervention study on MiniMed 780G system.10天内成功将1型糖尿病儿童和青少年从每日多次注射过渡到先进的混合闭环系统：关于美敦力780G系统的前瞻性干预研究
Acta Diabetol. 2022 May;59(5):743-746. doi: 10.1007/s00592-022-01851-w. Epub 2022 Jan 24.
6
Letter to the editor: Nuances from the manufacturer regarding the ABCD-DTN best practice guide on the use of MiniMed 780G advanced hybrid closed loop system.致编辑的信：制造商关于ABCD-DTN使用美敦力780G高级混合闭环系统最佳实践指南的细微差别。
Diabet Med. 2023 Sep;40(9):e15171. doi: 10.1111/dme.15171. Epub 2023 Jul 12.
7
Use of insulin pumps and closed-loop systems among people living with diabetes: A narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payers.胰岛素泵和闭环系统在糖尿病患者中的应用：临床和成本效益的叙述性综述，以实现技术的可及性并满足支付方的需求。
Diabetes Obes Metab. 2023 Jul;25 Suppl 2:21-32. doi: 10.1111/dom.15087. Epub 2023 Apr 26.
8
Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale.1 型糖尿病成人患者中使用高级混合闭环的随机对照试验（ADAPT）：研究方案和原理。
BMJ Open. 2022 Feb 2;12(2):e050635. doi: 10.1136/bmjopen-2021-050635.
9
First Randomized Controlled Trial of Hybrid Closed Loop Versus Multiple Daily Injections or Insulin Pump Using Self-Monitoring of Blood Glucose in Free-Living Adults with Type 1 Diabetes Undertaking Exercise.第一项针对1型糖尿病成年患者在自由生活状态下进行运动时，比较混合闭环系统与多次皮下注射或胰岛素泵并采用自我血糖监测的随机对照试验。
J Diabetes Sci Technol. 2021 Nov;15(6):1399-1401. doi: 10.1177/19322968211035110. Epub 2021 Jul 27.
10
Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.美敦力 670G 混合闭环系统与持续皮下胰岛素输注治疗 1 型糖尿病的成本效益分析。
Diabetes Technol Ther. 2019 Mar;21(3):110-118. doi: 10.1089/dia.2018.0328. Epub 2019 Feb 20.

本文引用的文献

1
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study.成人 1 型糖尿病的先进混合闭环治疗与常规治疗（ADAPT）：一项随机对照研究。
Lancet Diabetes Endocrinol. 2022 Oct;10(10):720-731. doi: 10.1016/S2213-8587(22)00212-1. Epub 2022 Sep 1.
2
A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden.对《致编辑的信：关于1型糖尿病患者使用先进混合闭环系统的成本效益：瑞典的一项健康经济分析》的回应
Diabetes Ther. 2022 May;13(5):1125-1129. doi: 10.1007/s13300-022-01252-w. Epub 2022 Apr 11.
3
Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.
1型糖尿病中间歇性扫描式连续血糖监测与先进混合闭环系统的成本效益：对Jendle等人研究的评论
Diabetes Ther. 2022 May;13(5):1121-1123. doi: 10.1007/s13300-022-01251-x. Epub 2022 Apr 11.
4
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.安全性和血糖控制效果：MiniMed™ 高级混合闭环系统在青少年和成年 1 型糖尿病患者中的关键性试验
Diabetes Technol Ther. 2022 Mar;24(3):178-189. doi: 10.1089/dia.2021.0319. Epub 2021 Nov 16.
5
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.比较实时和间歇性扫描连续血糖监测在 1 型糖尿病成人患者中的应用（ALERTT1）：一项 6 个月前瞻性多中心随机对照试验。
Lancet. 2021 Jun 12;397(10291):2275-2283. doi: 10.1016/S0140-6736(21)00789-3. Epub 2021 Jun 2.
6
Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial.《1 型糖尿病成人患者经皮指尖血糖监测的混合闭环与手动胰岛素输注 6 个月的随机对照试验》
Diabetes Care. 2020 Dec;43(12):3024-3033. doi: 10.2337/dc20-1447. Epub 2020 Oct 14.
7
One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.1 型糖尿病患儿和青少年使用混合闭环系统治疗 1 年的经验：取得成功的驱动因素。
Acta Diabetol. 2021 Feb;58(2):207-213. doi: 10.1007/s00592-020-01607-4. Epub 2020 Oct 12.
8
Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4).使用瞬态血糖监测仪（FLARE-NL4）一年后，患者的幸福感提高，疾病负担减轻。
BMJ Open Diabetes Res Care. 2019 Dec 9;7(1):e000809. doi: 10.1136/bmjdrc-2019-000809. eCollection 2019.
9
Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study.1 型糖尿病患者接受间歇性扫描连续血糖监测 1 年后的生活质量和血糖控制（FUTURE）：一项前瞻性观察性真实世界队列研究。
Diabetes Care. 2020 Feb;43(2):389-397. doi: 10.2337/dc19-1610. Epub 2019 Dec 16.
10
Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes.闭环系统与传感器增强型胰岛素泵治疗 1 型糖尿病患者的长期真实生活血糖控制效果比较。
Diabetes Obes Metab. 2020 Apr;22(4):583-589. doi: 10.1111/dom.13933. Epub 2020 Jan 3.